Clinical and experimental immunology 151-162

HIGHLIGHTS

• who: ZnT and colleagues from the Diabetes and Metabolism, Translational Health Sciences, Bristol Medical School, University of Bristol, Level, Learning and Research, Southmead Hospital, Bristol , NB, UK have published the paper: Clinical and Experimental Immunology 151-162, in the Journal: (JOURNAL)
• what: The strength of the study was the ability to account for baseline autoantibody positivity and titres, which the authors have shown, have the largest effect size with the persistence of humoral responses in the largest cohort of longitudinally sampled subjects with T1D.
• how: Data transformation and statistical analysis Data were analysed . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.